Pre-exposure Prophylaxis
88 results
1 - 88
Pre-exposure Prophylaxis
HIV- Characteristics Associated with Pre-Exposure Prophylaxis Discussion and Use Among Transgender Women Without HIV Infection - National HIV Behavioral Surveillance Among Transgender Women, Seven Urban Areas, United States, 2019-2020
- Dear Colleague: Preliminary Data on Pre-Exposure Prophylaxis Coverage Released
- Notice of Funding Opportunity PS23-001: Increasing PrEP Use Among Black Cisgender Women in the United States (HerPrEP)
- February 7 is National Black HIV/AIDS Awareness Day (NBHAAD)
Anthrax, Pre-exposure and Post-Exposure Prevention- Anthrax vaccine
- Anthrax vaccine
- Emtricitabine
- Emtricitabine
- Yersinia pestis
- Pemgarda (pemivibart)
- Rabies vaccines
Human Immunodeficiency Virus (HIV)- Treponema pallidum (syphilis)
- Rabies
- Coronavirus COVID-19 (SARS-CoV-2)
- Coronavirus COVID-19 (SARS-CoV-2)
- Molnupiravir
- Molnupiravir
Preventing HIV in 2025: Primary Care and Psychiatry at the Forefront of Prep- Intravenous immune globulin
- Intravenous immune globulin
- Hepatitis C
- Zanamivir
- Hepatitis A
- Jynneos vaccine
- Jynneos vaccine
- mpox
- mpox
- Chlamydia trachomatis
- Screening for and Prevention of Infectious Diseases in Special Populations
- Smallpox
- Toxoplasma gondii
- Pregnancy and perinatal transmission
- Japanese Encephalitis Vaccine
- Japanese Encephalitis Vaccine
- Beta-lactam allergy
- Primary HIV Infection
- Leptospira spp.
- Diarrhea
- Cytomegalovirus
- Chloroquine
- Ertapenem
- Plasmodium
- Prostatitis, Acute Bacterial
- Pneumocystis jirovecii pneumonia
Antimicrobials with Special Precautions in Diabetes- Varicella-zoster virus
- Voriconazole
- Voriconazole
- Clostridioides (ex. Clostridium) difficile